• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促红细胞生成素对血管生物学的影响。

Effects of epoetin on vascular biology.

作者信息

Vaziri N D, Ateshkadi A

机构信息

Department of Medicine, University of California, Irvine 92868, USA.

出版信息

Nephrol Dial Transplant. 1999;14 Suppl 2:46-9. doi: 10.1093/ndt/14.suppl_2.46.

DOI:10.1093/ndt/14.suppl_2.46
PMID:10334667
Abstract

In addition to promoting erythropoiesis, chronic administration of epoetin frequently increases blood pressure, ameliorates uraemic platelet dysfunction, enhances platelet production and elevates resting and stimulated cytosolic [Ca2+]. In addition, in vivo and in vitro studies have demonstrated that epoetin may modify production and activity of certain vasoactive factors and may promote vascular cell growth. Many of the latter effects of epoetin appear to be unrelated to the associated erythropoietic action of the hormone and must, therefore, involve other mechanisms. The present article is intended to provide a brief overview of the effects of epoetin on vascular and haemostatic systems.

摘要

除了促进红细胞生成外,长期使用促红细胞生成素通常会升高血压,改善尿毒症血小板功能障碍,增强血小板生成并提高静息和刺激状态下的胞质[Ca2+]浓度。此外,体内和体外研究表明,促红细胞生成素可能会改变某些血管活性因子的产生和活性,并可能促进血管细胞生长。促红细胞生成素的许多后一种作用似乎与该激素相关的促红细胞生成作用无关,因此必定涉及其他机制。本文旨在简要概述促红细胞生成素对血管和止血系统的影响。

相似文献

1
Effects of epoetin on vascular biology.促红细胞生成素对血管生物学的影响。
Nephrol Dial Transplant. 1999;14 Suppl 2:46-9. doi: 10.1093/ndt/14.suppl_2.46.
2
Defective calcium signalling in uraemic platelets and its amelioration with long-term erythropoietin therapy.
Nephrol Dial Transplant. 2002 Jun;17(6):992-7. doi: 10.1093/ndt/17.6.992.
3
Effects of Epoetin alfa on hemostasis in chronic renal failure.
Am J Nephrol. 1998;18(4):263-73. doi: 10.1159/000013349.
4
Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.促红细胞生成素(重组人促红细胞生成素)。对其药效学和药代动力学特性以及在贫血和刺激红细胞生成方面的治疗潜力的综述。
Drugs. 1989 Dec;38(6):863-99. doi: 10.2165/00003495-198938060-00004.
5
Epoetin enhances erythropoiesis in normal men undergoing repeated phlebotomies.
Clin Pharmacol Ther. 1992 Aug;52(2):205-13. doi: 10.1038/clpt.1992.131.
6
Epoetin delta as an antifibrotic agent in the remnant kidney rat: a possible role for transforming growth factor beta and hepatocyte growth factor.促红细胞生成素 delta 作为残肾大鼠的抗纤维化剂:转化生长因子 β 和肝细胞生长因子的可能作用。
Nephron Exp Nephrol. 2010;115(3):e46-59. doi: 10.1159/000313830. Epub 2010 Apr 24.
7
Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.促红细胞生成素、红细胞生成生物学及重组人促红细胞生成素α。综述。
J Reprod Med. 2001 May;46(5 Suppl):521-30.
8
In vivo and in vitro pressor effects of erythropoietin in rats.促红细胞生成素对大鼠的体内和体外升压作用
Am J Physiol. 1995 Dec;269(6 Pt 2):F838-45. doi: 10.1152/ajprenal.1995.269.6.F838.
9
Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure.一氧化氮抵抗在慢性肾衰竭大鼠促红细胞生成素诱导的高血压中的作用。
Am J Physiol. 1996 Jul;271(1 Pt 1):E113-22. doi: 10.1152/ajpendo.1996.271.1.E113.
10
Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease rats.聚乙二醇化促红细胞生成素β可预防慢性肾病大鼠中通过血流介导的血管舒张评估的内皮功能障碍。
Eur J Pharmacol. 2015 Nov 15;767:10-6. doi: 10.1016/j.ejphar.2015.09.034. Epub 2015 Sep 30.

引用本文的文献

1
Iron therapy in the pediatric hemodialysis population.儿科血液透析人群的铁剂治疗
Pediatr Nephrol. 2004 Jun;19(6):655-61. doi: 10.1007/s00467-004-1457-5. Epub 2004 Apr 3.
2
Past, present and future of erythropoietin use in the elderly.老年人使用促红细胞生成素的过去、现在与未来。
Int Urol Nephrol. 2002;33(1):187-93. doi: 10.1023/a:1014478704766.